The Effects of Nutritional Supplementation and Drug Abuse on HIV
NCT ID: NCT00149656
Last Updated: 2013-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
878 participants
INTERVENTIONAL
2003-06-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Micronutrients and Enteric Infections in African Children
NCT00133419
Rwanda Selenium Supplementation Clinical Trial
NCT01327755
Botswana Vitamin D Supplementation Study in HIV/AIDS
NCT02189902
Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection
NCT00197561
A Trial of Vitamins and HAART in HIV Disease Progression
NCT00383669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This trial will last 2 years. Participants will be randomly assigned to 4 groups: a combination of multivitamins with selenium, multivitamins alone, selenium alone, or placebo.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Placebo
placebo pill
2
Multivitamins
Multivitamins
dietary supplement of multivitamins
3
Multivitamins with Selenium
Multivitamins
dietary supplement of multivitamins
Selenium
dietary supplement of selenium only
4
Selenium
Selenium
dietary supplement of selenium only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multivitamins
dietary supplement of multivitamins
Selenium
dietary supplement of selenium only
Placebo
placebo pill
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CD4 count greater than 350 cells/mm3
* Identified from the Infectious Disease Care Clinic
* Body mass index greater than 18 for women and greater than 18.5 for men
Exclusion Criteria
* Currently participating in another clinical trial
* Pregnant or intends to become pregnant during the study
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Florida International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marianna K. Baum, PhD
Role: PRINCIPAL_INVESTIGATOR
Florida International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Princess Marina Hospital
Gaborone, , Botswana
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R01-16551-1
Identifier Type: -
Identifier Source: secondary_id
DPMC
Identifier Type: -
Identifier Source: secondary_id
NIDA-16551-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.